PI3K

Phosphoinositide 3-kinases (PI3Ks) are lipid kinases that catalyze the phosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) to generate the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P₃). The production of PI(3,4,5)P₃ facilitates the recruitment and activation of pleckstrin homology (PH) domain–containing proteins at the plasma membrane, thereby initiating downstream signaling cascades essential for cellular proliferation, survival, and migration.

PI3Ks are divided into three major classes, among which Class I PI3Ks are most prominently implicated in cancer biology. Class I enzymes comprise four distinct catalytic isoforms: PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ.

Class IA PI3Ks, the subclass most commonly associated with oncogenic signaling, function as heterodimeric lipid kinases composed of a catalytic p110 subunit (p110α, p110β, or p110δ, encoded by PIK3CA, PIK3CB, and PIK3CD, respectively) and a regulatory p85 subunit.

The PI3K signaling pathway plays a central role in diverse biological processes, including cell cycle progression, cellular growth, survival, actin cytoskeletal rearrangement, migration, and intracellular vesicular trafficking.

Frequently Asked Questions
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate phosphatidylinositol lipids to regulate cell growth, survival, metabolism, and immune signaling. PI3K activation leads to downstream AKT and mTOR pathway signaling. Aberrant PI3K signaling is frequently observed in cancer due to PIK3CA mutations, PTEN loss, or receptor tyrosine kinase activation.
Class I PI3Ks include four catalytic isoforms: PI3Kα (PIK3CA) PI3Kβ (PIK3CB) PI3Kδ (PIK3CD) PI3Kγ (PIK3CG) PI3Kα and β are broadly expressed, while PI3Kδ and γ are enriched in leukocytes and play critical roles in immune regulation. Isoform selectivity is an important consideration in drug development due to toxicity and immune effects.
PI3K inhibitors can be classified as: Pan-PI3K inhibitors Isoform-selective inhibitors (α, β, δ, γ) Dual PI3K/mTOR inhibitors Irreversible inhibitors Selectivity influences therapeutic window and toxicity profile.
While PI3K inhibitors block upstream lipid kinase activity, mTOR inhibitors act downstream at the level of mTORC1 or mTORC2. Dual PI3K/mTOR inhibitors target both nodes of the pathway and may achieve broader pathway suppression.

Items 101-125 of 411

  • Leniolisib
    Cat. No.
    A16796

    Leniolisib (CDZ 173)

    Synonyms: CDZ-173; Leniosilib

    Leniolisib(CDZ 173) is a potent PI3Kδ selective inhibitor with biochemical IC50 values of 0.244, 0.424, 2.23 and 0.011 μM for PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ, respectively.

    1 mg
    $65.00
    2 mg
    $105.00
    All 8 sizes
  • Seletalisib
    Cat. No.
    A16797

    Seletalisib (UCB-5857)

    Synonyms: UCB-5857

    Seletalisib is a novel small-molecule inhibitor of PI3Kδ with an IC50 value of 12 nM and shows significant selectivity to PI3Kδ with respect to the other class I PI3K isoforms (between 24- and 303-fold).

    1 mg
    $45.00
    2 mg
    $65.00
    All 8 sizes
  • Tenalisib
    Cat. No.
    A16799

    Tenalisib (RP6530)

    Synonyms: RP-6530

    Tenalisib, also known as RP6530, is a potent and selective dual PI3Kδ/γ inhibitor that inhibited growth of B-cell lymphoma cell lines with a concomitant reduction in the downstream biomarker, pAKT.

    1 mg
    $25.00
    2 mg
    $40.00
    All 8 sizes
  • IPI-3063
    Cat. No.
    A16800

    IPI-3063

    IPI-3063 is a potent and selective p110δ inhibitor with biochemical IC50 of 2.5±1.2 nM and IC50 values for the other class I PI3K isoforms (p110α, p110β, p110γ) are at least 400-fold higher.

    1 mg
    $30.00
    2 mg
    $50.00
    All 8 sizes
  • 2-D08
    Cat. No.
    A16852

    2-D08

    2-D08 is a cell permeable, mechanistically unique inhibitor of protein sumoylation. It is also inhibits Axl, IRAK4, ROS1, MLK4, GSK3β, RET, KDR and PI3Kα with IC50 values of 0.49, 3.9, 5.3, 9.8, 11, 11, 17 and 35 nM respectively in biochemical assays.

    5 mg
    $45.00
    10 mg
    $80.00
    All 6 sizes
  • SAR260301
    Cat. No.
    A16877

    SAR260301

    SAR260301 is potent and selective Class I phosphatidylinositol-3-kinase (PI3K)β specific inhibitor with an IC50 of 52 nM for this isoform.

    2 mg
    $30.00
    5 mg
    $55.00
    All 8 sizes
  • Vps34-IN-2
    Cat. No.
    A16933

    Vps34-IN-2

    Vps34-IN-2 is a novel, potent and selective inhibitor of Vps34 with IC50s of 2 and 82 nM on the Vps34 enzymatic assay and the GFP-FYVE cellular assay, respectively.

    1 mg
    $185.00
    2 mg
    $355.00
    All 7 sizes
  • 4-Methylbenzylidene camphor
    Cat. No.
    A17293

    4-Methylbenzylidene camphor

    Synonyms: 4-MBC; Enzacamene

    4-Methylbenzylidene camphor(4-MBC; Enzacamene)is an organic camphor derivative that is used in the cosmetic industry for its ability to protect the skin against UV, specifically UV B radiation.

    500 mg
    $25.00
    1 g
    $35.00
    All 5 sizes
  • Hyaluronic acid sodium
    Cat. No.
    A17713

    Hyaluronic acid sodium

    Synonyms: Sodium hyaluronate

    Hyaluronic acid sodium, also known as sodium hyaluronate, is a glycosaminoglycan that plays a crucial role in the extracellular matrix (ECM). This biopolymer is involved in key biological activities such as cell proliferation, tissue remodeling, and angiogenesis, particularly in the context of digestive cancers. Hyaluronic acid sodium is implicated in tumor cell growth and migration, and it activates the PI3K-Akt signaling pathway. This reagent can also be utilized in research related to joint diseases, wound healing, and as a drug delivery system to enhance the efficacy of therapeutics in cancer research.

    50 mg
    $20.00
    100 mg
    $25.00
    All 7 sizes
  • MTX-211
    Cat. No.
    A18324

    MTX-211

    MTX-211 is a dual inhibitor of EGFR and PI3K, which plays important roles in the progression of KRAS mutant colorectal cancer. MTX-211 has the potential for the treatment of KRAS mutant colorectal cancer.

    1 mg
    $50.00
    2 mg
    $90.00
    All 9 sizes
  • P110δ-IN-1
    Cat. No.
    A18348

    P110δ-IN-1

    Synonyms: ME401; PWT143

    P110δ-IN-1 is a potent and selective inhibitor of P110δ extracted from patent WO 2014055647 A1, with an IC50 of 8.4 nM.

    1 mg
    $35.00
    5 mg
    $80.00
    All 6 sizes
  • alpha-Bisabolol
    Cat. No.
    A18691

    alpha-Bisabolol

    alpha-Bisabolol is a nontoxic sesquiterpene alcohol present in natural essential oil, with anticancer activity. alpha-Bisabolol exerts selective anticancer effect on A549 NSCLC cells (IC50=15 μM) via induction of cell cycle arrest, mitochondrial apoptosis and inhibition of PI3K/Akt signalling pathways. alpha-Bisabolol also strongly induces apoptosis in glioma cells.

    500 mg
    $45.00
    1 g
    $75.00
    All 2 sizes
  • PQR-530
    Cat. No.
    A19209

    PQR-530

    PQR-530 is a potent, oral and brain-penetrant dual pan-PI3K/mTORC1/2 inhibitor, exhibiting antitumor activity.

    1 mg
    $20.00
    5 mg
    $60.00
    All 7 sizes
  • PI3Kdelta inhibitor 1
    Cat. No.
    A19249

    PI3Kdelta inhibitor 1

    PI3Kdelta inhibitor 1 (Compound 5d) is a potent, selective and orally available PI3Kδ inhibitor with an IC50 of 1.3 nM.

    1 mg
    $200.00
    5 mg
    $500.00
    All 6 sizes
  • PI3Kδ-IN-1
    Cat. No.
    A19582

    PI3Kδ-IN-1

    PI3Kδ-IN-1 is a potent, selective, and efficacious PI3Kδ inhibitor with an IC50 of 1.7 nM.

    1 mg
    $50.00
    5 mg
    $140.00
    All 6 sizes
  • PI3Kγ inhibitor 2
    Cat. No.
    A19606

    PI3Kγ inhibitor 2

    PI3Kγ inhibitor 2 (Compound 16) is an orally bioavailable, CNS-penetrant, isoform selective PI3Kγ inhibitor with a Ki of 4 nM.

    1 mg
    $315.00
    5 mg
    $955.00
    All 6 sizes
  • PI3K/mTOR Inhibitor-2
    Cat. No.
    A19621

    PI3K/mTOR Inhibitor-2

    PI3K/mTOR Inhibitor-2 is a potent dual pan-PI3K/mTOR inhibitor with IC50s of 3.4/34/16/1 nM for PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ and 4.7 nM for mTOR. Antitumor activity.

    1 mg
    $45.00
    5 mg
    $140.00
    All 8 sizes
  • CHMFL-PI3KD-317
    Cat. No.
    A19990

    CHMFL-PI3KD-317

    CHMFL-PI3KD-317 is a highly potent, selective and orally active PI3Kδ inhibitor, with an IC50 of 6 nM.

    1 mg
    $85.00
    5 mg
    $220.00
    All 7 sizes
  • PI3K/mTOR Inhibitor-1
    Cat. No.
    A20055

    PI3K/mTOR Inhibitor-1

    PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual PI3K/mTOR inhibitor with IC50s of 20/376/204/46 nM and 186 nM for PI3Kα/PI3Kβ/PI3Kγ/PI3Kδ and mTOR, respectively. Antitumor activity.

    1 mg
    $315.00
    5 mg
    $955.00
    All 6 sizes
  • 740 Y-P
    Cat. No.
    A20138

    740 Y-P

    Synonyms: 740YPDGFR; PDGFR 740Y-P

    740 Y-P (740YPDGFR; PDGFR 740Y-P) is a potent and cell-permeable PI3K activator. 740 Y-P readily binds GST fusion proteins containing both the N- and C- terminal SH2 domains of p85 but fails to bind GST alone.

    1 mg
    $80.00
    2 mg
    $130.00
    All 6 sizes
  • IITZ-01
    Cat. No.
    A20192

    IITZ-01

    Synonyms: Autophagy inhibitor IITZ-01

    IITZ-01 is a potent lysosomotropic autophagy inhibitor with single-agent antitumor activity, with an IC50 of 2.62 μM for PI3Kγ.

    5 mg
    $30.00
    10 mg
    $50.00
    All 7 sizes

Items 101-125 of 411

Added to your cart

View Cart Checkout

    Loading...